Pediatric Hypertension [[electronic resource] /] / edited by Joseph T. Flynn, Julie R. Ingelfinger, Karen Redwine |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 |
Disciplina | 616.12 |
Soggetto topico |
Cardiology
Pediatrics Nephrology |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Neurohumoral and Autonomic Regulation of Blood Pressure -- Vasoactive Factors and Blood Pressure in Children -- Cardiovascular Influences on Blood Pressure -- Ions and Fluid Dynamics in Hypertension -- Uric Acid in the Pathogenesis of Hypertension -- Insulin resistance and other mechanisms of obesity hypertension -- Monogenic and Polygenic Genetic Contributions to Hypertension -- Perinatal Programming and Blood Pressure -- Hereditability and Familial Aggregation of Blood Pressure -- Dietary Sodium, Potassium and Calcium and Childhood BP -- Endothelial Dysfunction and Vascular Remodeling in Hypertension -- Stress and salt sensitivity in Childhood Hypertension -- Methodology of Casual Blood Pressure Measurement -- Value of routine screening for hypertension in childhood -- Blood Pressure Norms and Definition of Hypertension in Children -- Ambulatory Blood Pressure Methodology and Norms in Children -- Epidemiology of Primary Hypertension in Children -- Epidemiology of Cardiovascular Disease in Children and Adolescents -- Ethnic Differences in Childhood Blood Pressure -- Obesity Hypertension: Clinical Aspects -- Hypertension in children with type 2 diabetes or the metabolic syndrome -- Primary Hypertension in Children -- Secondary Forms of Hypertension in Children: Overview -- Hypertension in Chronic Kidney Disease -- Hypertension in End-Stage Renal Disease: Dialysis -- Hypertension in End-Stage Renal Disease: Transplantation -- Renovascular HTN, Vasculitis and Aortic Coarctation -- Endocrine Hypertension -- Neonatal Hypertension -- Sleep Apnea and Hypertension -- Hypertension in the pregnant teenager -- Cognitive and Behavioral Aspects of Childhood hypertension -- Substance-induced hypertension: Mechanisms and management -- Hypertension in oncology and stem-cell transplant patients -- Hypertension in older adolescents and young adults -- Hypertension in the Developing World -- Diagnostic Evaluation of Pediatric Hypertension -- Sequelae of Hypertension in Children and Adolescents -- Vascular and cardiac imaging techniques and their applicability to childhood hypertension -- The Role of ABPM in Evaluation of Hypertensive Target-organ Damage -- Exercise Testing in Hypertension and Hypertension in Athletes -- Nonpharmacologic Treatment of Pediatric Hypertension -- Pharmacologic Treatment of Pediatric Hypertension -- Management of Hypertensive Emergencies -- Hypertensive Models and Their Relevance to Pediatric Hypertension -- Cohort studies, Meta-Analyses and Clinical Trials -- Changes in Drug Development Regulations and Their Impact on Clinical Trials. . |
Record Nr. | UNINA-9910349366003321 |
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Pediatric Hypertension / / edited by Joseph T. Flynn, Julie R. Ingelfinger, Karen M. Redwine |
Edizione | [4th ed. 2018.] |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018 |
Descrizione fisica | 1 online resource (84 illus., 46 illus. in color. eReference.) |
Disciplina | 618.92132 |
Soggetto topico |
Cardiology
Pediatrics Nephrology |
ISBN | 3-319-31107-7 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Neurohumoral and Autonomic Regulation of Blood Pressure -- Vasoactive Factors and Blood Pressure in Children -- Cardiovascular Influences on Blood Pressure -- Ions and Fluid Dynamics in Hypertension -- Uric Acid in the Pathogenesis of Hypertension -- Insulin Resistance and Other Mechanisms of Obesity Hypertension -- Monogenic and Polygenic Contributions to Hypertension -- Perinatal Programming of Arterial Pressure -- Hereditability and Familial Aggregation of Blood Pressure -- The Role of Dietary Electrolytes and Childhood Blood Pressure Regulation -- Endothelial Dysfunction and Vascular Remodeling in Hypertension -- Stress and Salt Sensitivity in Childhood Hypertension -- Methodology of Casual Blood Pressure Measurement -- Value of Routine Screening for Hypertension in Childhood -- Development of Blood Pressure Norms and Definition of Hypertension in Children -- Ambulatory Blood Pressure Monitoring Methodology and Norms in Children -- Methodology and Applicability of Home Blood Pressure Monitoring in Children and Adolescents: Home Blood Pressure Monitoring -- Epidemiology of Primary Hypertension in Children -- Epidemiology of Cardiovascular Disease in Children -- Ethnic Differences in Childhood Blood Pressure -- Obesity Hypertension: Clinical Aspects -- Hypertension in Children with Type 2 Diabetes or the Metabolic Syndrome -- Primary Hypertension in Children -- Secondary Forms of Hypertension in Children: Overview -- Hypertension in Chronic Kidney Disease -- Hypertension in End-Stage Renal Disease: Dialysis -- Hypertension in End-Stage Renal Disease: Transplantation -- Renovascular Hypertension, Vasculitis, and Aortic Coarctation -- Endocrine Hypertension -- Neonatal and Infant Hypertension -- Obstructive Sleep Apnea and Hypertension -- Hypertension in the Pregnant Teenager -- Cognitive and Behavioral Aspects of Childhood Hypertension -- Substance-Induced Hypertension: Mechanisms and Management -- Hypertension in Oncology and Stem-Cell Transplant Patients -- Hypertension in Older Adolescents and Young Adults -- Hypertension in the Developing World -- Diagnostic Evaluation of Pediatric Hypertension -- Sequelae of Hypertension in Children and Adolescents -- Vascular and Cardiac Imaging Techniques and Their Applicability to Childhood Hypertension -- The Role of ABPM in Evaluation of Hypertensive Target-Organ Damage -- Exercise Testing in Hypertension and Hypertension in Athletes -- Nonpharmacologic Treatment of Pediatric Hypertension -- Pharmacologic Treatment of Pediatric Hypertension -- Management of Hypertensive Emergencies -- Hypertensive Models and Their Relevance to Pediatric Hypertension -- Cohort Studies, Meta-analyses, and Clinical Trials in Childhood Hypertension -- Changes in Drug Development Regulations and Their Impact on Clinical Trials. . |
Record Nr. | UNINA-9910300293203321 |
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Pediatric hypertension / / Joseph T. Flynn, Julie R. Ingelfinger, Ronald J. Portman, editors |
Edizione | [3rd ed. 2013.] |
Pubbl/distr/stampa | New York, : Springer Science, 2013 |
Descrizione fisica | 1 online resource (xvi, 600 pages) : illustrations (some color) |
Disciplina |
618.92
618.92132 |
Altri autori (Persone) |
FlynnJoseph T
IngelfingerJulie R PortmanRonald J |
Collana | Clinical hypertension and vascular diseases |
Soggetto topico |
Hypertension in children
Pediatric cardiology |
ISBN | 1-62703-490-0 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Foreword; Preface; Contents; Contributors; Part I: Regulation of Blood Pressure and Pathophysiological Mechanisms of Hypertension; 1: Neurohumoral and Autonomic Regulation of Blood Pressure; Introduction; Overview of Autonomic Function; Vasoactive Sites in the Brain; Tonic Autonomic Activity; Arterial Baroreflex; Resetting of the Arterial Baroreflex; Autonomic Function During Human Development; Cardiopulmonary Reflex; Peripheral Chemoreflex; Sympathetic Activity at Birth; Humoral Factors (See Also Chaps. 1 and 2); Renin-Angiotensin-Aldosterone System; Arginine Vasopressin; Glucocorticoids
Nitric OxideReactive Oxygen Species; Conclusion; References; 2: Vasoactive Factors and Blood Pressure in Children; Introduction; Renin-Angiotensin-Aldosterone System; Angiotensinogen; Prorenin, Renin, and (Pro)renin Receptor; Angiotensin-Converting Enzyme; Angiotensin II Receptors; Angiotensin-Converting Enzyme 2; Developmental Aspects of the RAAS; Aldosterone; Glucocorticoids; Kallikrein-Kinin System; Arginine Vasopressin; Endothelium-Derived Vasoactive Factors; Nitric Oxide; Asymmetrical Dimethylarginine; Endothelin; Natriuretic Peptides Vasoactive Factors and Developmental Programming of HypertensionRenalase; Summary; References; 3: Cardiovascular Influences on Blood Pressure; Introduction; Cardiac Output; Preload; Venous Tone; Circulating Blood Volume; Cardiopulmonary Baroreceptors; Natriuretic Peptides; The Kidney and Blood Volume; Chronic Changes in Preload and Hypertension; Cardiac Contractility; Chronic Changes in Cardiac Contractility and Hypertension; Afterload; Chronic Increase in Afterload and Myocardial Hypertrophy; Determinants of Systolic, Diastolic, and Mean Blood Pressure; Systemic Vascular Resistance Local Vascular Regulatory MechanismsAutonomic Nervous System Control of Vascular Resistance; Baroreceptors; Baroreceptors and Hypertension; Chemoreceptors and Osmoreceptors; Hypothalamus and Medulla Oblongata and Hypertension; Vasoactive Peptides; The Renin-Angiotensin-Aldosterone System; Endothelin and the Cardiovascular System; Vasopressin and Hypertension; Summary; References; 4: Ion and Fluid Dynamics in Hypertension; Sodium Channels; NHE Transporters; NKCC Transporters; The NCCT; ENaC; Na + /K + ATPase; Calcium Flux; Regulation of Ion Flux; Sodium Distribution and Blood Pressure ConclusionsReferences; 5: Uric Acid in the Pathogenesis of Hypertension; The History of Uric Acid and Hypertension; Animal Models of Hyperuricemic Hypertension; Epidemiology; Uric Acid Metabolism; Pediatric Clinical Trials; Conclusions; References; 6: Monogenic and Polygenic Contributions to Hypertension; Introduction; Monogenic Forms of Human Hypertension; Glucocorticoid-Remediable Aldosteronism or Familial Hyperaldosteronism Type 1 [OMIM #103900]; Familial Hyperaldosteronism Type 2 OMIM #605635; Familial Hyperaldosteronism Type 3 [OMIM# 613677]: Apparent Mineralocorticoid Excess [AME] [OMIM # 218030] |
Record Nr. | UNINA-9910438004303321 |
New York, : Springer Science, 2013 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|